Beauty Farm Medical and Health Industry Inc. executed an on-market repurchase of 17,000 ordinary shares on 4 May 2026, paying a volume-weighted average price of HKD 20.42 per share and spending a total of HKD 0.35 million.

Following the transaction, treasury shares rose from 1.76 million to 1.78 million, while the number of issued shares outstanding (excluding treasury stock) declined by 17,000 to 249.82 million—equivalent to a 0.0068% reduction in free float.

The repurchase forms part of the mandate approved on 27 June 2025, which authorises the company to buy back up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 1.78 million shares, representing 0.75% of the share count when the mandate was granted.

Under Hong Kong listing regulations, Beauty Farm Medical is restricted from issuing new shares or disposing of treasury shares until 3 June 2026.